Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies with attractive risk-reward profiles. Our valuation framework helps you find stocks with the right balance of growth and value characteristics for your portfolio. We provide P/E analysis, PEG ratios, and relative valuation metrics for comprehensive valuation coverage. Find value in growth with our comprehensive valuation analysis and multiples tools for growth at a reasonable price strategies.
As of April 22, 2026, Cardlytics Inc. (CDLX) trades at a current price of $0.97, posting a minor gain of 0.24% in today’s session. This analysis outlines key technical levels, market context, and potential near-term scenarios for the purchase-linked marketing platform operator, with no recent earnings data available to inform updated financial performance assessments. CDLX has traded in a tight range in recent weeks, with clearly identifiable support and resistance levels that market participant
Cardlytics (CDLX) Stock Momentum Trade (Buying Pressure) 2026-04-22 - Capital Preservation
CDLX - Stock Analysis
3875 Comments
1060 Likes
1
Jazani
Engaged Reader
2 hours ago
This would’ve helped me make a better decision.
👍 23
Reply
2
Wala
Senior Contributor
5 hours ago
Incredible execution and vision.
👍 11
Reply
3
Leyanna
Senior Contributor
1 day ago
The market is showing resilience despite minor volatility, with indices trading above key moving averages. Profit-taking is minimal, and technical indicators suggest that upward momentum remains intact. Short-term traders should watch for breakout signals to confirm trend continuation.
👍 185
Reply
4
Vadie
Expert Member
1 day ago
This would’ve helped me avoid second guessing.
👍 125
Reply
5
Moire
Engaged Reader
2 days ago
I can’t help but think “what if”.
👍 206
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.